Benitec Biopharma (BNTC) Amortizatization of Intangibles (2019 - 2025)

Benitec Biopharma has disclosed Amortizatization of Intangibles across 7 years of filings, most recently posting $106000.0 for Q4 2025.

• Amortizatization of Intangibles for Q4 2025 came in at $106000.0, up 260.61% year-over-year; the trailing twelve-month figure through Dec 2025 was $541000.0 (up 316.15% YoY), and the FY2025 annual result was $330000.0, up 28.91% from the prior year.
• Amortizatization of Intangibles came in at $106000.0 for Q4 2025 at Benitec Biopharma, up from $105000.0 in the prior quarter.
• In the past five years, Amortizatization of Intangibles ranged from a high of $330000.0 in Q2 2025 to a low of -$66000.0 in Q4 2024.
• The 5-year median for Amortizatization of Intangibles is $61000.0 (2022), against an average of $71842.1.
• Across the five-year window, Amortizatization of Intangibles plunged 204.76% in 2024 and soared 407.69% in 2025, its largest moves.
• Benitec Biopharma's Amortizatization of Intangibles stood at $58000.0 in 2021, then gained by 5.17% to $61000.0 in 2022, then rose by 3.28% to $63000.0 in 2023, then slumped by 204.76% to -$66000.0 in 2024, then jumped by 260.61% to $106000.0 in 2025.
• The last three Amortizatization of Intangibles figures came in at $106000.0 (Q4 2025), $105000.0 (Q3 2025), and $330000.0 (Q2 2025), per Business Quant data.